Penny S. Toren departed as Senior Vice President, Regulatory Affairs & Project Management at GRI Bio, Inc..
“On April 19, 2022, Penny S. Toren's position as Senior Vice President, Regulatory Affairs & Project Management of Vallon Pharmaceuticals, Inc. (the "Company") was eliminated, effective immediately, as part of the Company's effort to streamline its operations in order to preserve its capital and cash resources and not as the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices or in any way for cause.”
Ofir Levi resigned as Chairman of the Board at GRI Bio, Inc..
“On March 28, 2022, Ofir Levi resigned as a member of the Board of Directors (the “Board”) of Vallon Pharmaceuticals, Inc. (the “Company”) and as Chairman of the Board.”
Meenu Karson was appointed as director at GRI Bio, Inc..
“increased the size of the Board from five directors to six directors and appointed Meenu Karson to serve as a member of the Board”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.